At the end of January 2025, the U.S. government revealed its intentions to impose tariffs on imported pharmaceuticals, steel, and computer chips. This action seeks to strengthen local manufacturing and tackle trade imbalances. Yet, these steps might profoundly impact global trade relations, especially influencing major U.S. partners in Asia.
Effect on Semiconductor Sector
Impact on Semiconductor Industry
The semiconductor sector is poised to be significantly affected by these proposed tariffs. Asia dominates global chip production, accounting for over 80% of the world’s semiconductors. Leading companies such as Taiwan Semiconductor Manufacturing Co. (TSMC) and South Korea’s Samsung Electronics and SK Hynix are major suppliers to the U.S. market. For instance, TSMC, the world’s largest contract chipmaker, derives approximately 70% of its revenue from North American clients, including tech giants like Nvidia and Apple. While TSMC is investing in a $65 billion manufacturing facility in Arizona, the majority of its production remains in Taiwan, making it susceptible to the proposed tariffs. Similarly, Samsung and SK Hynix, which together control around 75% of the global DRAM market, could face challenges due to their substantial exports to the U.S.
The pharmaceutical industry is also a key target of the proposed tariffs. Japanese pharmaceutical enterprises, such as Takeda, Astellas, Daiichi Sankyo, and Eisai, hold considerable interests in the U.S. market. For instance, Takeda noted that more than half of its revenue in the previous fiscal year was generated from the U.S., whereas Astellas mentioned that 41% of its earnings were derived from the U.S. market. Tariffs on imported pharmaceuticals might disrupt their operations and financial outcomes, potentially resulting in higher costs for U.S. consumers.
The pharmaceutical industry is another focal point of the proposed tariffs. Japanese pharmaceutical companies, including Takeda, Astellas, Daiichi Sankyo, and Eisai, have significant stakes in the U.S. market. For example, Takeda reported that over half of its revenue in the last financial year originated from the U.S., while Astellas indicated that 41% of its revenue came from the U.S. market. Tariffs on imported pharmaceuticals could disrupt their operations and financial performance, potentially leading to increased costs for U.S. consumers.
The introduction of tariffs on steel imports aims to rejuvenate domestic steel manufacturing. Nonetheless, these measures might raise costs for sectors dependent on steel, such as the automotive and construction industries. Increased input costs could cause higher prices for consumers and possible interruptions in supply chains. Additionally, these tariffs may put pressure on relationships with major trading partners and trigger retaliatory actions, further complicating the landscape of international trade.
International Trade Ties and Possible Retaliation
The suggested tariffs have raised apprehensions among U.S. allies in Asia. Nations such as Taiwan, South Korea, and Japan, which play crucial roles in the global supply chains for semiconductors and pharmaceuticals, could face economic hurdles due to diminished competitiveness in the U.S. market. These countries might attempt to negotiate exemptions or contemplate imposing retaliatory tariffs on U.S. exports, potentially initiating a series of trade conflicts.
Consideraciones Económicas Nacionales
Domestic Economic Considerations
While the tariffs aim to promote domestic manufacturing, they could have mixed effects on the U.S. economy. Importers are likely to pass increased costs onto consumers, leading to higher prices for goods such as electronics and medications. Additionally, industries dependent on imported components may face challenges in sourcing materials, potentially hindering production and innovation. Economists caution that such protectionist measures could disrupt supply chains and may not yield the intended benefits of job creation in the targeted industries.
